Citations (57)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Kevin O. St. Arnaud. (2023) Toward a positive psychology of psychoactive drug use. Drugs: Education, Prevention and Policy 30:1, pages 81-94.
Read now
Read now
Giovanna Ricci, Francesco Paolo Busardò, Filippo Gibelli, Ascanio Sirignano & Pietro Brunetti. (2021) Evaluating the risk of toxicity and adverse drug interactions involving recreational GHB use and prescribed drugs. Expert Opinion on Drug Metabolism & Toxicology 17:12, pages 1445-1454.
Read now
Read now
Gina Martin, Kate Vallance, Scott Macdonald, Tim Stockwell, Andrew Ivsins, Clifton Chow, Warren Michelow & Cameron Duff. (2014) Nonfatal overdose from alcohol and/or drugs among a sample of recreational drug users. Journal of Substance Use 19:3, pages 239-244.
Read now
Read now
Wei-Hsi Chen, Chi Chui & Hsin-Ling Yin. (2012) The Antemortem Neurobehavior in Fatal Paramethoxymethamphetamine Usage. Substance Abuse 33:4, pages 366-372.
Read now
Read now
Susan Y. Kim, Ilene B. Anderson, Jo Ellen Dyer, Judith C. Barker & Paul D. Blanc. (2007) High-Risk Behaviors and Hospitalizations Among Gamma Hydroxybutyrate (GHB) Users. The American Journal of Drug and Alcohol Abuse 33:3, pages 429-438.
Read now
Read now
Lydia N. Drumright, Thomas L. Patterson & Steffanie A. Strathdee. (2006) Club Drugs as Causal Risk Factors for HIV Acquisition Among Men Who Have Sex with Men: A Review. Substance Use & Misuse 41:10-12, pages 1551-1601.
Read now
Read now
Articles from other publishers (51)
Iman Bhia, Mitra Rahimi, Mohammad Poursalehian, Babak Mostafazadeh, Peyman Erfan Talab Evini & Shahin Shadnia. (2023) Ketamine overdose: A case series from a referral poison center in Iran. Psychiatry Research Case Reports 2:2, pages 100191.
Crossref
Crossref
Alessandro Riccardi, Mario Guarino, Sossio Serra, Michele Spampinato, Simone Vanni, Dana Shiffer, Antonio Voza, Andrea Fabbri & Fabio De Iaco. (2023) Narrative Review: Low-Dose Ketamine for Pain Management. Journal of Clinical Medicine 12:9, pages 3256.
Crossref
Crossref
Nicholas M. Zwolinski, Kaiwal S. Patel, Nalini Vadivelu, Gopal Kodumudi & Alan David Kaye. (2023) ERAS Protocol Options for Perioperative Pain Management of Substance Use Disorder in the Ambulatory Surgical Setting. Current Pain and Headache Reports 27:5, pages 65-79.
Crossref
Crossref
Luis Henríquez-Hernández, Jaime Rojas-Hernández, Domingo Quintana-Hernández & Lucas Borkel. (2023) Hofmann vs. Paracelsus: Do Psychedelics Defy the Basics of Toxicology?—A Systematic Review of the Main Ergolamines, Simple Tryptamines, and Phenylethylamines. Toxics 11:2, pages 148.
Crossref
Crossref
Vyacheslav Kushakov, Vira Dvoriak, Olga Morozova, Lyu Azbel & Galyna Sergienko. (2022) Psychoactive substance use and drug checking practices among participants at electronic dance music events in Ukraine. Drugs, Habits and Social Policy 23:3, pages 244-257.
Crossref
Crossref
Patrycja Kleczkowska & Malgorzata Zaremba. 2022. Ketamine Revisited - New Insights into NMDA Inhibitors. Ketamine Revisited - New Insights into NMDA Inhibitors.
Annie M. McCartney, Hugh T McGovern & Alexander De Foe. (2022) Psychedelic assisted therapy for major depressive disorder: Recent work and clinical directions. Journal of Psychedelic Studies 6:1, pages 10-22.
Crossref
Crossref
Raquel Bennett, Christian Yavorsky & Gary Bravo. (2022) Ketamine for Bipolar Depression: Biochemical, Psychotherapeutic, and Psychedelic Approaches. Frontiers in Psychiatry 13.
Crossref
Crossref
Beatrice Mainoli, Nilza Gonçalves, Joaquim J. Ferreira & Bruno Mégarbane. (2021) Potential drug‐drug interactions in acute poisonings managed in the intensive care unit: Occurrence, risk factors and relationship to patient severity on admission. Basic & Clinical Pharmacology & Toxicology 130:2, pages 337-345.
Crossref
Crossref
Yanning Li, Zhibin Dong, Gehua Wen, Xinghua Ren, Weishu Ren, Lei Yan, Xiaolong Wang, Hao Yu, Xue Wu, Xi Xia, Yan Lu & Xu Wu. (2021) Long‐term ketamine administration induces bladder damage and upregulates autophagy‐associated proteins in bladder smooth muscle tissue. Environmental Toxicology 36:12, pages 2521-2529.
Crossref
Crossref
Mateusz Kowalczyk, Edward Kowalczyk, Paweł Kwiatkowski, Łukasz Łopusiewicz, Monika Sienkiewicz & Monika Talarowska. (2021) Ketamine—New Possibilities in the Treatment of Depression: A Narrative Review. Life 11:11, pages 1186.
Crossref
Crossref
Ramadhan ORUCH, Ian F. PRYME, Ole B. FASMER & Anders LUND. (2021) Ketamine: use in psychiatry, its pharmacology and treatment following intoxication. Minerva Psychiatry 62:3.
Crossref
Crossref
Alan K. Davis, Frederick S. Barrett, Darrick G. May, Mary P. Cosimano, Nathan D. Sepeda, Matthew W. Johnson, Patrick H. Finan & Roland R. Griffiths. (2021) Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder. JAMA Psychiatry 78:5, pages 481.
Crossref
Crossref
G. F. Brum, H. Z. Rosa, D. R. Rossato, J. L. O. Rosa, V. G. Metz, L. H. Milanesi & M. E. Burger. (2020) Binge and Subchronic Exposure to Ketamine Promote Memory Impairments and Damages in the Hippocampus and Peripheral Tissues in Rats: Gallic Acid Protective Effects. Neurotoxicity Research 38:2, pages 274-286.
Crossref
Crossref
Fan Chen, Yi Ye, Xinhua Dai, Yuzi Zheng, Shiyong Fang & Linchuan Liao. (2020) Metabolic effects of repeated ketamine administration in the rat brain. Biochemical and Biophysical Research Communications 522:3, pages 592-598.
Crossref
Crossref
Qing Li, Hui-ran Wu, Shu-juan Fan, De-xiang Liu, Hong Jiang, Qian Zhang & Fang Pan. (2019) The effects of sub-anesthetic ketamine plus ethanol on behaviors and apoptosis in the prefrontal cortex and hippocampus of adolescent rats. Pharmacology Biochemistry and Behavior 184, pages 172742.
Crossref
Crossref
Matthew D. Krasowski. 2019. Critical Issues in Alcohol and Drugs of Abuse Testing. Critical Issues in Alcohol and Drugs of Abuse Testing
225
236
.
Roberta Monteiro Incrocci, Franciely Paliarin & Manoel Jorge Nobre. (2018) Prelimbic NMDA receptors stimulation mimics the attenuating effects of clozapine on the auditory electrophysiological rebound induced by ketamine withdrawal. NeuroToxicology 69, pages 1-10.
Crossref
Crossref
Karyn Bischoff. 2018. Veterinary Toxicology. Veterinary Toxicology
385
408
.
Zurina Hassan, Oliver G. Bosch, Darshan Singh, Suresh Narayanan, B. Vicknasingam Kasinather, Erich Seifritz, Johannes Kornhuber, Boris B. Quednow & Christian P. Müller. (2017) Novel Psychoactive Substances—Recent Progress on Neuropharmacological Mechanisms of Action for Selected Drugs. Frontiers in Psychiatry 8.
Crossref
Crossref
Yu Liu, Deyong Lin, Boliang Wu & Wenhua Zhou. (2016) Ketamine abuse potential and use disorder. Brain Research Bulletin 126, pages 68-73.
Crossref
Crossref
Chau-kiu Cheung & Steven Sek-yum Ngai. (2014) Encouraging the Disuse of Illicit Drugs Among At-Risk Youth. International Journal of Offender Therapy and Comparative Criminology 60:6, pages 640-656.
Crossref
Crossref
Joseph J. Palamar, Marybec Griffin-Tomas & Danielle C. Ompad. (2015) Illicit drug use among rave attendees in a nationally representative sample of US high school seniors. Drug and Alcohol Dependence 152, pages 24-31.
Crossref
Crossref
Gyula Bokor & Peter D. Anderson. (2014) Ketamine. Journal of Pharmacy Practice 27:6, pages 582-586.
Crossref
Crossref
Zhou Lü, Xiandun Zhai, Haimei Zhou, Pu Li, Jinqi Ma, Ling Guan & Yaonan Mo. (2014)
Effects of Ketamine on the Development of forensically important Blowfly
Chrysomya megacephala
(F.) (Diptera: Calliphoridae) and its Forensic Relevance
. Journal of Forensic Sciences 59:4, pages 991-996.
Crossref
Crossref
Lin Sun, Qi Li, Qing Li, Yuzhe Zhang, Dexiang Liu, Hong Jiang, Fang Pan & David T. Yew. (2012) Chronic ketamine exposure induces permanent impairment of brain functions in adolescent cynomolgus monkeys. Addiction Biology 19:2, pages 185-194.
Crossref
Crossref
M. E. Sutter, J. Chenoweth & T. E. Albertson. (2013) Alternative Drugs of Abuse. Clinical Reviews in Allergy & Immunology 46:1, pages 3-18.
Crossref
Crossref
Patricia Graciela Schneider & Georgina Rodríguez de Lores Arnaiz. (2013) Ketamine prevents seizures and reverses changes in muscarinic receptor induced by bicuculline in rats. Neurochemistry International 62:3, pages 258-264.
Crossref
Crossref
Kevin Woodward & Kevin WoodwardK. N. Woodward. 2012. Toxicological Effects of Veterinary Medicinal Products in Humans. Toxicological Effects of Veterinary Medicinal Products in Humans
117
149
.
Naren Gunja. (2011) Teenage toxins: Recreational poisoning in the adolescent. Journal of Paediatrics and Child Health 48:7, pages 560-566.
Crossref
Crossref
Celia J. A. Morgan & H. Valerie Curran. (2011) Ketamine use: a review. Addiction 107:1, pages 27-38.
Crossref
Crossref
Karyn Bischoff. 2012. Veterinary Toxicology. Veterinary Toxicology
469
489
.
L Sun, WP Lam, YW Wong, LH Lam, HC Tang, MS Wai, YT Mak, F Pan & DT Yew. (2010) Permanent deficits in brain functions caused by long-term ketamine treatment in mice. Human & Experimental Toxicology 30:9, pages 1287-1296.
Crossref
Crossref
A.W. Jones, F.C. Kugelberg, A. Holmgren & J. Ahlner. (2011) Drug poisoning deaths in Sweden show a predominance of ethanol in mono-intoxications, adverse drug–alcohol interactions and poly-drug use. Forensic Science International 206:1-3, pages 43-51.
Crossref
Crossref
Deborah L. Zvosec, Stephen W. Smith, Trinka Porrata, A. Quinn Strobl & Jo Ellen Dyer. (2011) Case series of 226 γ-hydroxybutyrate–associated deaths: lethal toxicity and trauma. The American Journal of Emergency Medicine 29:3, pages 319-332.
Crossref
Crossref
L.Y. Yeung, Maria S.M. Wai, Ming Fan, Y.T. Mak, W.P. Lam, Zhen Li, Gang Lu & David T. Yew. (2010) Hyperphosphorylated tau in the brains of mice and monkeys with long-term administration of ketamine. Toxicology Letters 193:2, pages 189-193.
Crossref
Crossref
Ying T. Mak, Wai P. Lam, Lanhai Lü, Yeuk W. Wong & David T. Yew. (2009) The toxic effect of ketamine on SH‐SY5Y neuroblastoma cell line and human neuron. Microscopy Research and Technique 73:3, pages 195-201.
Crossref
Crossref
Leon Gussow & Andrea Carlson. 2010. Rosen's Emergency Medicine – Concepts and Clinical Practice. Rosen's Emergency Medicine – Concepts and Clinical Practice
2071
2079
.
Laurent Karila, Johanne Novarin, Bruno Megarbane, Olivier Cottencin, Sylvain Dally, William Lowenstein & Michel Reynaud. (2009) Acide gamma-hydroxy-butyrique (GHB) : plus qu’un agent de soumission chimique, une véritable source d’addiction. La Presse Médicale 38:10, pages 1526-1538.
Crossref
Crossref
Sharlene Kaye, Shane Darke & Johan Duflou. (2009) Methylenedioxymethamphetamine (MDMA)-related fatalities in Australia: Demographics, circumstances, toxicology and major organ pathology. Drug and Alcohol Dependence 104:3, pages 254-261.
Crossref
Crossref
Gail Winger, Chad M. Galuska & Steven R. Hursh. (2007) Modification of ethanol’s reinforcing effectiveness in rhesus monkeys by cocaine, flunitrazepam, or gamma-hydroxybutyrate. Psychopharmacology 193:4, pages 587-598.
Crossref
Crossref
Robert S. Gable. (2006) Risk assessment of ritual use of oral dimethyltryptamine (DMT) and harmala alkaloids. Addiction 102:1, pages 24-34.
Crossref
Crossref
Karyn Bischoff. 2007. Veterinary Toxicology. Veterinary Toxicology
391
410
.
Tamaki Hayase, Yoshiko Yamamoto & Keiichi Yamamoto. (2006) Behavioral effects of ketamine and toxic interactions with psychostimulants. BMC Neuroscience 7:1.
Crossref
Crossref
Jeffrey T. Parsons, Brian C. Kelly & Brooke E. Wells. (2006) Differences in club drug use between heterosexual and lesbian/bisexual females. Addictive Behaviors 31:12, pages 2344-2349.
Crossref
Crossref
MERRILL SINGER, HASSAN SALAHEEN, GREG MIRHEJ & CLAUDIA SANTELICE. (2008) Bridging the Divide: Drinking among Street Drug Users. American Anthropologist 108:3, pages 502-506.
Crossref
Crossref
Jørgen G. Bramness, Svetlana Skurtveit & Jørg Mørland. (2006) Flunitrazepam: Psychomotor impairment, agitation and paradoxical reactions. Forensic Science International 159:2-3, pages 83-91.
Crossref
Crossref
Polák Robert. (2006) Is ecstasy a dangerous drug?. Kontakt 8:1, pages 149-153.
Crossref
Crossref
Kim Wolff & Adam R Winstock. (2006) Ketamine. CNS Drugs 20:3, pages 199-218.
Crossref
Crossref
Jan Copeland & Paul Dillon. (2005) The health and psycho-social consequences of ketamine use. International Journal of Drug Policy 16:2, pages 122-131.
Crossref
Crossref
Francisca Charliane Carlos Da Silva, Rodrigo Tavares Dantas, Maria d do Carmo de Oliveira Citó, Silvânia Maria Mendes De Vasconcelos, Marta Maria de França Fonteles, Glauce Socorro de Barros Viana & Francisca Cléa Florenço De Sousa. (2001) Ketamina, da anestesia ao uso abusivo. Revista Neurociências 18:2, pages 227-237.
Crossref
Crossref